Trevi Therapeutics, Inc. (TRVI)

NASDAQ: TRVI · Real-Time Price · USD

11.70

-1.60 (-12.03%)

At close: Mar 9, 2026, 4:00 PM EDT

11.98

+0.28 (2.39%)

After-hours: Mar 9, 2026, 7:02 PM EDT

Trevi Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	56.87	34.1	32.4	12.59	36.83	45
Short-Term Investments	138.06	73.53	50.57	107.92	-	-
Cash & Short-Term Investments	194.93	107.62	82.97	120.51	36.83	45
Cash Growth	197.63%	29.71%	-31.15%	227.21%	-18.16%	-21.48%
Other Current Assets	3.37	1.81	4.58	2.11	1.13	1.27
Total Current Assets	198.3	109.43	87.55	122.62	37.96	46.27
Net Property, Plant & Equipment	0.95	1.23	1.56	0.19	0.18	0.33
Other Long-Term Assets	0.1	0.24	0.3	0.21	0.33	0.53
Total Assets	199.36	110.9	89.4	123.02	38.48	47.13
Accounts Payable	2.71	3.41	1.81	2.86	2.85	2.02
Accrued Expenses	6.04	6.81	3.71	3.52	3.81	3.43
Current Portion of Long-Term Debt	-	-	-	7	5.83	-
Current Portion of Leases	0.3	0.29	0.31	0.03	0.12	0.11
Other Current Liabilities	-	-	-	-	0.11	-
Total Current Liabilities	9.04	10.51	5.82	13.4	12.72	5.56
Long-Term Debt	-	-	-	2.15	8.65	13.95
Long-Term Leases	0.53	0.75	1.03	0	0.02	0.14
Other Long-Term Liabilities	-	-	-	0	-	0.2
Total Long-Term Liabilities	0.53	0.75	1.03	2.16	8.68	14.29
Total Liabilities	9.57	11.26	6.86	15.56	21.4	19.85
Common Stock	0.13	0.09	0.07	0.06	0.03	0.02
Additional Paid-in Capital	511.12	386.53	321.64	317.59	197.96	174.24
Accumulated Other Comprehensive Income	0.03	0.06	-0.03	-0.12	-	-
Retained Earnings	-321.49	-287.05	-239.13	-210.07	-180.92	-146.98
Shareholders' Equity	189.79	99.64	82.55	107.46	17.08	27.28
Total Liabilities & Equity	199.36	110.9	89.4	123.02	38.48	47.13
Total Debt	0.82	1.03	1.34	9.18	14.63	14.21
Net Cash (Debt)	194.1	106.59	81.63	111.33	22.2	30.79
Net Cash Growth	82.10%	30.57%	-26.68%	401.47%	-27.89%	-45.94%
Net Cash Per Share	1.56	1.04	0.82	1.73	0.97	1.71
Book Value	189.79	99.64	82.55	107.46	17.08	27.28
Book Value Per Share	1.52	0.98	0.83	1.66	0.75	1.51
Tangible Book Value	189.79	99.64	82.55	107.46	17.08	27.28
Tangible Book Value Per Share	1.52	0.98	0.83	1.66	0.75	1.51

Updated Nov 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q